Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

Registrieren

ZVRA Zevra Therapeutics Inc

8,0101

-0,0899 (-1,11%)

25 Jan 2025 - Geschlossen

Verzögert um 15 Minuten

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Zevra Therapeutics (NASDAQ:ZVRA)
Historical Stock Chart
Von Dez 2024 bis Jan 2025

Click Here for more Zevra Therapeutics Charts.

Zevra Therapeutics (NASDAQ:ZVRA)
Historical Stock Chart
Von Jan 2024 bis Jan 2025

Click Here for more Zevra Therapeutics Charts.

News Zevra Therapeutics Inc

Zevra Therapeutics to be Added to Nasdaq Biotechnology Index (Nasdaq: NBI) Effective December 23, 2024
Dienstag 17 Dezember 2024 (1 Monat vor) • GlobeNewswire Inc.

Form 8-K - Current report
Freitag 6 Dezember 2024 (2 Monate vor) • Edgar (US Regulatory)

Zevra Therapeutics Announces Organizational Changes
Freitag 6 Dezember 2024 (2 Monate vor) • GlobeNewswire Inc.

Zevra Therapeutics to Participate at Upcoming Investor Conferences
Dienstag 26 November 2024 (2 Monate vor) • GlobeNewswire Inc.

Zevra Therapeutics Announces U.S. Commercial Availability of MIPLYFFA™ (arimoclomol) for Treatment of Niemann-Pick Disease Type C
Donnerstag 21 November 2024 (2 Monate vor) • GlobeNewswire Inc.

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Donnerstag 14 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Donnerstag 14 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mittwoch 13 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Dienstag 12 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Zevra Therapeutics Reports Third Quarter 2024 Financial Results and Corporate Updates
Dienstag 12 November 2024 (2 Monate vor) • GlobeNewswire Inc.

Zevra Therapeutics to Present Data Demonstrating Relevance of Swallow Domain in Niemann-Pick Disease Type C Clinical Severity Scale at 53rd Child Neurology Society Annual Meeting
Montag 11 November 2024 (2 Monate vor) • GlobeNewswire Inc.

Zevra Therapeutics to Participate at the Guggenheim Securities Healthcare Innovation Conference on Wed, Nov. 13
Mittwoch 6 November 2024 (3 Monate vor) • GlobeNewswire Inc.

Weitere Zevra Therapeutics Inc News-Artikel

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen